3 completed, 1 active not recruiting, 1 recruiting, 1 withdrawn. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Active not recruiting 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Recruiting 1 |
Follow Radioembolization: new trials by email Literature Review of Radioembolization trials Research Report on Radioembolization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial Angiogram, Biospecimen Collection, Computed Tomography - Stage I Renal Cell Cancer, Stage II Renal Cell Cancer | Phase 1 / Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 25 | 2024-12-26 | 2026-08-21 |
| Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC Durvalumab, Radioembolization - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Completed | Seoul National University Hospital | 24 | 2020-06-12 | 2023-03-16 |
| Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer Angiography, Computed Tomography, Planar Imaging - Metastatic Liver Carcinoma, Stage IV Liver Cancer | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 12 | 2017-01-09 | 2026-09-16 |
| Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery Capecitabine, Laboratory Biomarker Analysis, Radioembolization - Bile Duct Adenocarcinoma, Stage III Intrahepatic Cholangiocarcinoma | Phase 1 | Withdrawn | City of Hope Medical Center | 2016-12-01 | 2017-04-18 | |
| Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) doxorubicin, superabsorbent polymer microspheres, embolotherapy - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Completed | University of British Columbia | 24 | 2010-01-01 | 2014-03-17 |
| Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma Sorafenib, Yttrium-90 (Y-90) - Hepatocellular Carcinoma | Phase 1 | Completed | Northwestern University | 24 | 2009-02-01 | 2016-09-15 |
Carcinoma, Hepatocellular (4) · Carcinoma, Renal Cell (1) · Cholangiocarcinoma (1) · Liver Neoplasms (1)
City of Hope Medical Center (1) · Jonsson Comprehensive Cancer Center (1) · M.D. Anderson Cancer Center (1) · Northwestern University (1) · Seoul National University Hospital (1) · University of British Columbia (1)
United States (4) · Canada (1) · South Korea (1)
Alan Weiss, MD (1) · Armeen Mahvash (1) · Charles Scudamore, MD (1) · David Owen, MD (1) · Ellen Wasan, PhD (1) · Eric Yoshida, MD (1) · Jo-Ann Ford, RN (1) · Jonathan Kessler, MD (1) · Laura Kulik, MD (1) · Riad Salem, MD (1) · Sharlene Gill, MD (1) · Siddharth A Padia (1) · Sigfried Erb, MD (1) · Stephen Chung, MD (1) · Stephen Ho, MD (1)
PMID 23703789, PMID 24681342, PMID 24982375, PMID 41276366
P30CA016672 (1)